PURA Planned 1 For 1 Dividend Receives $0.015 12-Month Target Value
September 11 2020 - 11:59AM
InvestorsHub Cannabis NewsWire
Dallas, TX -- September 11, 2020 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced recent analyst research pertaining to the
upcoming planned shareholder dividend for prompt distribution where
shareholders are to receive one share of PAO Group, Inc. (USOTC:
PAOG) for every PURA share
held.
Goldman Small Cap Research earlier this
week released an update to a previous research report covering
PAOG’s cannabis biopharmaceutical business. The update
included a $0.015
12-month target PPS.
The dividend has been declared. A
date of record is pending the necessary process to be set, and a
prompt distribution is planned thereafter. Management did
anticipate the date of record process already being complete at
this time and expects to have a date
imminently.
A second shareholder dividend is in the
works and the transaction that would result in the dividend
issuance is anticipated to be complete by the end of this
month.
Prior to
entering into the cannabis marketplace with the acquisition of
patented cannabis extraction process licenses, PURA worked in the
development of proprietary water purification technologies.
PURA's legacy personal water purification product, Filter2Go
remains for sale online to include
distribution through Amazon.com.
PURA has been
approached by a party looking to acquire PURA's legacy water
purification assets. The deal under discussion would involve
an exchange of stock in a public company for PURA's water
purification assets. PURA management would in turn issue the
purchase stock to PURA shareholders through a dividend distribution
similarly to the dividend distribution underway in conjunction with
PURA's recent sale of its cannabis cultivation assets to
PAOG.
For more
information on Puration, visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Aug 2024 to Sep 2024
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Sep 2023 to Sep 2024